首页> 美国卫生研究院文献>Therapeutic Advances in Medical Oncology >MKK7 the essential regulator of JNK signaling involved in cancer cell survival: a newly emerging anticancer therapeutic target
【2h】

MKK7 the essential regulator of JNK signaling involved in cancer cell survival: a newly emerging anticancer therapeutic target

机译:MKK7是参与癌细胞存活的JNK信号转导的重要调节剂:一种新兴的抗癌治疗靶标

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

One of the mitogen-activated protein kinases (MAPKs), c-Jun NH2-terminal protein kinase (JNK) plays an important role in regulating cell fate, such as proliferation, differentiation, development, transformation, and apoptosis. Its activity is induced through the interaction of MAPK kinase kinases (MAP3Ks), MAPK kinases (MAP2Ks), and various scaffolding proteins. Because of the importance of the JNK cascade to intracellular bioactivity, many studies have been conducted to reveal its precise intracellular functions and mechanisms, but its regulatory mechanisms remain elusive. In this review, we discuss the molecular characterization, activation process, and physiological functions of mitogen-activated protein kinase kinase 7 (MKK7), the MAP2K that most specifically controls the activity of JNK. Understanding the role of MKK7/JNK signaling in physiological conditions could spark new hypotheses for targeted anticancer therapies.
机译:c-Jun NH2末端蛋白激酶(JNK)是一种促分裂原激活的蛋白激酶(MAPK),在调节细胞命运(例如增殖,分化,发育,转化和凋亡)中起着重要作用。它的活性是通过MAPK激酶激酶(MAP3Ks),MAPK激酶(MAP2Ks)和各种支架蛋白的相互作用来诱导的。由于JNK级联对细胞内生物活性的重要性,已经进行了许多研究以揭示其确切的细胞内功能和机制,但其调控机制仍然难以捉摸。在这篇综述中,我们讨论了有丝分裂原激活的蛋白激酶激酶7(MKK7)的分子特征,激活过程和生理功能,MAP2K最能控制JNK的活性。了解MKK7 / JNK信号在生理条件下的作用可能会引发针对靶向抗癌治疗的新假设。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号